PDIA3 and laryngeal carcinoma: Moreover, PDIA3 modulates radioresistance of laryngeal cancer cells by directly activating STAT3 and, in turn, triggers increased Mcl-1 expression, thereby contributing to tumor radioresistance of laryngeal cancer cells and poor outcomes in patients with laryngeal cancer in response to radiotherapy [32].